These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1010710)

  • 1. Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
    Singh MM
    Int Pharmacopsychiatry; 1976; 11(4):232-4. PubMed ID: 1010710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
    Sachdev P; Tang WM
    Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia syndrome in neuroleptic therapy. General considerations and clinical observations on forty cases investigated.
    Chiriţă V; Boişteanu P; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(1):53-64. PubMed ID: 2889249
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):601-5. PubMed ID: 18193111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazepam in tardive dyskinesia.
    Weber SS; Dufresne RL; Becker RE; Mastrati P
    Drug Intell Clin Pharm; 1983; 17(7-8):523-7. PubMed ID: 6135591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.
    Lew TY; Tollefson G
    Biol Psychiatry; 1983 Dec; 18(12):1441-6. PubMed ID: 6661471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
    Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD
    Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia iron in tardive dyskinesia: an MRI study.
    Elkashef AM; Egan MF; Frank JA; Hyde TM; Lewis BK; Wyatt RJ
    Biol Psychiatry; 1994 Jan; 35(1):16-21. PubMed ID: 8167198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose diazepam in neuroleptic-resistant schizophrenia with tardive dyskinesia.
    Eapen V; Mukherjee D; Chandra P; Sinha V; Khanna S; Channabasavanna SM
    J Clin Psychiatry; 1989 Aug; 50(8):309. PubMed ID: 2569459
    [No Abstract]   [Full Text] [Related]  

  • 15. Risperidone treatment of tardive dyskinesia and dystonia.
    Chong SA; Remington G; Tan CH
    J Clin Psychiatry; 1999 May; 60(5):340-1. PubMed ID: 10362448
    [No Abstract]   [Full Text] [Related]  

  • 16. [Improvement of tardive dyskinesia after treatment with olanzapine].
    Truöl S; Von Hippel C; Raape J; König F
    Psychiatr Prax; 2002 Sep; 29(6):315-7. PubMed ID: 12224042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 18. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.